Literature DB >> 16831381

[Adverse drug reactions: an update review of the problem in Spain].

E Puche Cañas1, J de Dios Luna.   

Abstract

Adverse drug reactions (ADR) are an important clinical problem and their impact on the Spanish population is unknown. The aim of this study was to provide an overview of ADR based on a review of observational studies published in Spain since 1974. Twenty-seven studies of Spanish patients were selected from a total of 90 articles published in national and international journals between 1974 and 2004. Studies eligible for inclusion were identified with an especially designed checklist. The incidence of ADR among 139,799 patients was 3%; 0.6% of the events led to death, and 17% led to severe illness. Two-thirds (67%) of the ADR were classified as type A. The rate of hospitalization for ADR was 6.5%, and mean length stay was 4 +/- 1.3 days. Thirteen percent of the ADR were considered confirmed, and 57% were considered probable. Half (50%) of the ADR were considered preventable. The groups of medications involved most frequently were antibacterial, NSAID, psychoactive medications, bronchodilators, digoxin, non-opiate analgesics, vasodilators, antidiabetics and loop diuretics. The organs and systems involved most frequently were the digestive tract, skin, central nervous system, cardiovascular, endocrine and respiratory systems. The factors associated most strongly with ADR were advanced age and use of multiple medications. The relationships of gender, previous history of ADR and comorbidity with the incidence of ADR have yet to be established. This review of ADR provides useful information on the incidence of ADR in the Spanish population and serves as a baseline for future studies.

Entities:  

Mesh:

Year:  2006        PMID: 16831381     DOI: 10.1157/13090482

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  2 in total

1.  Adverse drug reaction monitoring in a secondary care hospital in South India.

Authors:  R Arulmani; S D Rajendran; B Suresh
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

Review 2.  Impact of sample size on variation of adverse events and preventable adverse events: systematic review on epidemiology and contributing factors.

Authors:  Constanze Lessing; Astrid Schmitz; Bernhard Albers; Matthias Schrappe
Journal:  Qual Saf Health Care       Date:  2010-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.